XML 55 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Employee Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Stock-based compensation expense is included on the Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) based upon the job functions of the employees receiving the grants.  Compensation expense related to EOG's stock-based compensation plans for the years ended December 31, 2018, 2017 and 2016 was as follows (in millions):
 
2018
 
2017
 
2016
 
 
 
 
 
 
Lease and Well
$
51

 
$
41

 
$
38

Gathering and Processing Costs
1

 
1

 
1

Exploration Costs
25

 
23

 
21

General and Administrative
78

 
69

 
68

Total
$
155

 
$
134

 
$
128

Vesting Schedule
These revised vesting schedules will apply to all future grants as well, until revised, amended or otherwise determined by the Committee.
Grant Type
 
Previous Vesting Schedule
 
Revised Vesting Schedule
Stock Options/SARs
 
Vesting in 25% increments on each of the first four anniversaries of the date of grant
 
Vesting in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the date of grant
 
 
 
 
 
Restricted Stock/Restricted Stock Units
 
"Cliff" vesting five years from the date of grant
 
"Cliff" vesting three years from the date of grant
 
 
 
 
 
Performance Units
 
"Cliff" vesting five years from the date of grant (except for the December 2016 grant, which will "cliff" vest approximately three years from the date of grant)
 
"Cliff" vesting approximately 41 months from the date of grant - specifically, on the February 28th immediately following the Committee’s certifications contemplated by the form of award agreement governing grants of performance units
Weighted Average Fair Values and Valuation Assumptions
Weighted average fair values and valuation assumptions used to value stock option, SAR and ESPP grants for the years ended December 31, 2018, 2017 and 2016 were as follows:
 
Stock Options/SARs
 
ESPP
 
2018
 
2017
 
2016
 
2018
 
2017
 
2016
 
 
 
 
 
 
 
 
 
 
 
 
Weighted Average Fair Value of Grants
$
33.46

 
$
23.95

 
$
25.78

 
$
25.75

 
$
22.20

 
$
19.21

Expected Volatility
28.23
%
 
28.28
%
 
31.54
%
 
24.59
%
 
27.12
%
 
36.55
%
Risk-Free Interest Rate
2.68
%
 
1.52
%
 
0.78
%
 
1.89
%
 
0.88
%
 
0.44
%
Dividend Yield
0.72
%
 
0.75
%
 
0.76
%
 
0.64
%
 
0.71
%
 
0.82
%
Expected Life
5.0 years

 
5.1 years

 
5.4 years

 
0.5 years

 
0.5 years

 
0.5 years

Schedule of Share Based Compensation Arrangement By Share Based Payment Award
The following table sets forth the stock option and SAR transactions for the years ended December 31, 2018, 2017 and 2016 (stock options and SARs in thousands):
 
2018
 
2017
 
2016
 
Number
of Stock
Options/
SARs
 
Weighted
Average
Grant
Price
 
Number
of Stock
Options/
SARs
 
Weighted
Average
Grant
Price
 
Number
of Stock
Options/
SARs
 
Weighted
Average
Grant
Price
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at January 1
9,103

 
$
83.89

 
9,850

 
$
75.53

 
10,744

 
$
67.98

Granted
1,906

 
126.49

 
2,274

 
96.27

 
1,855

 
94.82

Exercised (1)
(2,493
)
 
72.21

 
(2,574
)
 
61.12

 
(2,376
)
 
54.56

Forfeited
(206
)
 
94.43

 
(447
)
 
93.84

 
(373
)
 
87.38

Outstanding at December 31
8,310

 
96.90

 
9,103

 
83.89

 
9,850

 
75.53

Stock Options/SARs Exercisable at December 31
3,969

 
85.82

 
4,510

 
75.76

 
5,613

 
66.48

 
(1)
The total intrinsic value of stock options/SARs exercised during the years 2018, 2017 and 2016 was $118 million, $95 million and $84 million, respectively.  The intrinsic value is based upon the difference between the market price of the Common Stock on the date of exercise and the grant price of the stock options/SARs.
Stock Options and SARs Outstanding and Exercisable
The following table summarizes certain information for the stock options and SARs outstanding and exercisable at December 31, 2018 (stock options and SARs in thousands):
Stock Options/SARs Outstanding
 
Stock Options/SARs Exercisable
Range of
Grant
Prices
 
Stock
Options/
SARs
 
Weighted
Average
Remaining
Life
(Years)
 
Weighted
Average
Grant
Price
 
 
 
Aggregate
Intrinsic
Value(1)
 
Stock
Options/
SARs
 
Weighted
Average
Remaining
Life
(Years)
 
Weighted
Average
Grant
Price
 
 
 
Aggregate
Intrinsic
Value (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$ 50.00 to $  82.99
 
1,528

 
3
 
$
65.46

 
 
 
1,183

 
2
 
$
64.27

 
  
 83.00 to    95.99
 
2,046

 
4
 
91.48

 
 
 
1,290

 
3
 
89.50

 
  
   96.00 to     96.99
 
1,961

 
6
 
96.29

 
 
 
618

 
5
 
96.29

 
  
   97.00 to   125.99
 
957

 
3
 
102.77

 
 
 
872

 
3
 
101.91

 
  
 126.00 to   129.99
 
1,818

 
7
 
127.01

 
 
 
6

 
1
 
127.00

 
  
 
 
8,310

 
5
 
96.90

 
$
35,083

 
3,969

 
3
 
85.82

 
$
28,993

 
(1)
Based upon the difference between the closing market price of the Common Stock on the last trading day of the year and the grant price of in-the-money stock options and SARs.
ESPP Activity
The following table summarizes ESPP activity for the years ended December 31, 2018, 2017 and 2016 (in thousands, except number of participants):
 
2018
 
2017
 
2016
 
 
 
 
 
 
Approximate Number of Participants
1,934

 
1,870

 
1,746

Shares Purchased
180

 
180

 
212

Aggregate Purchase Price
$
14,887

 
$
13,997

 
$
13,787

Restricted Stock and Restricted Stock Unit Transactions
The following table sets forth the restricted stock and restricted stock unit transactions for the years ended December 31, 2018, 2017 and 2016 (shares and units in thousands):
 
2018
 
2017
 
2016
 
Number of Shares and Units
 
Weighted Average Grant Date Fair Value
 
Number of Shares and Units
 
Weighted Average Grant Date Fair Value
 
Number of Shares and Units
 
Weighted Average Grant Date Fair Value
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at January 1
3,905

 
$
88.57

 
3,962

 
$
79.63

 
4,908

 
$
70.35

Granted
812

 
117.55

 
1,095

 
97.34

 
853

 
88.01

Released (1)
(740
)
 
78.16

 
(929
)
 
61.51

 
(1,465
)
 
53.95

Forfeited
(185
)
 
92.12

 
(223
)
 
85.45

 
(334
)
 
77.29

Outstanding at December 31 (2)
3,792

 
96.64

 
3,905

 
88.57

 
3,962

 
79.63

 
(1)
The total intrinsic value of restricted stock and restricted stock units released during the years ended December 31, 2018, 2017 and 2016 was $84 million, $91 million and $124 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date restricted stock and restricted stock units are released.
(2)
The total intrinsic value of restricted stock and restricted stock units outstanding at December 31, 2018, 2017 and 2016 was $331 million, $421 million and $401 million, respectively.
Weighted Average Fair Values and Valuation Assumptions for Performance Units/Stocks
      Weighted average fair values and valuation assumptions used to value Performance Awards during the years ended December 31, 2018, 2017 and 2016 were as follows:
 
2018
 
2017
 
2016
 
 
 
 
 
 
Weighted Average Fair Value of Grants
$
136.74

 
$
113.81

 
$
119.10

Expected Volatility
29.92
%
 
32.19
%
 
32.48
%
Risk-Free Interest Rate
2.85
%
 
1.60
%
 
1.15
%
Performance Unit and Performance Stock Transactions
The following table sets forth the Performance Award transactions for the years ended December 31, 2018, 2017 and 2016 (shares and units in thousands):
 
2018
 
2017
 
2016
 
Number of Units and Shares
 
 
Weighted Average Price per Grant Date
 
Number of Units and Shares
 
Weighted Average Price per Grant Date
 
Number of Units and Shares
 
Weighted Average Price per Grant Date
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at January 1
502

 
 
$
90.96

 
545

 
$
80.92

 
405

 
$
74.93

Granted
113

 
 
125.73

 
78

 
96.29

 
132

 
100.95

Granted for Performance Multiple (1)
72

 
 
101.87

 
119

 
84.43

 
142

 
56.21

Released (2)
(148
)
 
 
84.43

 
(240
)
 
66.69

 
(134
)
 
56.21

Forfeited

 
 

 

 

 

 

Outstanding at December 31 (3)
539

(4
)
 
101.53

 
502

 
90.96

 
545

 
80.92

 
(1)
Upon completion of the Performance Period for the Performance Awards granted in 2014, 2013 and 2012, a performance multiple of 200% was applied to each of the grants resulting in additional grants of Performance Awards in February 2018, 2017 and 2016.
(2)
The total intrinsic value of Performance Awards released during the years ended December 31, 2018, 2017 and 2016 was $18 million, $24 million and $10 million, respectively.
(3)
The total intrinsic value of Performance Awards outstanding at December 31, 2018, 2017 and 2016 was $47 million, $54 million and $55 million, respectively.
(4)
Upon the application of the relevant performance multiple at the completion of each of the remaining Performance Periods, a minimum of 144 and a maximum of 934 Performance Awards could be outstanding. The intrinsic value is based upon the closing price of EOG's common stock on the date Performance Awards are released.